Fineotex Chemical DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.80×0.82×0.77×0.77×0.78×
1.21×1.26×1.20×1.11×1.06×
15.2%15.7%22.1%25.0%21.0%
0.78×0.78×0.78×1.17×1.36×
1.23×1.23×1.10×1.21×1.19×
14.1%15.6%17.6%30.1%27.9%
13.5%13.5%18.4%30.1%28.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FCL₹51.19

Fineotex Chemical Limited

· Chemicals
₹ CrorePeersEPIGRALYASHOGUJALKALIFOSECOINDVISHNUGALAXYSURFTATVAJUBLCPLMcap ₹5,961 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.780.770.770.820.80
Interest Burden (Pretax/EBIT) ×1.061.111.201.261.21
EBIT Margin %20.9525.0222.1315.7115.18
Asset Turnover ×1.361.170.780.780.78
Financial Leverage (Assets/Equity) ×1.191.211.101.231.23
ROE (5-step product, year-end total equity) %27.9230.0817.6115.5814.09
ROE (owners' profit / average owners' equity) %28.9230.1118.3713.4813.48
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.